Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	92791
Country	United States

Received	2024-02-05 18:42
Peer-Review Started	2024-02-05 18:42
To Make the First Decision
Return for Revision	2024-03-05 04:49
Revised	2024-04-04 05:39
Second Decision	2024-04-24 02:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-24 09:40
Articles in Press	2024-04-24 09:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-14 06:00
Publish the Manuscript Online	2024-05-23 09:02

ISSN	2150-5330 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping
Manuscript Source	Unsolicited Manuscript
All Author List	Shahid Habib
Funding Agency and Grant Number
Corresponding Author	Shahid Habib, MD, Doctor, Doctor, Researcher, Department of Hepatology, Liver Institute PLLC, 3232 E Speedway Bvd, Tucson, AZ 85718, United States. shabib@liverinstitutepllc.org
Key Words	Metabolic dysfunctions-associated steatotic liver disease; Visceral obesity; Genetics; Diabetes; Insulin resistance
Core Tip	Metabolic dysfunctions-associated steatotic liver disease (MASLD) is a pathogenically heterogeneous disease with dynamic pathological features. The cardiometabolic risk of MASLD varies based on underlying etiopathogenic processes. Four subtypes of MASLD have been identified: Diabetic, non-diabetic (insulin resistance), genetic and mixed. These subtypes have not been clearly defined yet as separate entities. Given such heterogeneity, the behavior and outcome of MASLD in each patient is expected to be different. Therefore, a single drug is not expected to work for all patients with MASLD. The natural history of MASLD subtypes is unknown. There is an unmet need to categorize its subtypes and prospective studies are needed to characterize each subtype.
Publish Date	2024-05-23 09:02
Citation	<p>Habib S. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. <i>World J Gastrointest Pathophysiol</i> 2024; 15(2): 92791</p>
URL	https://www.wjgnet.com/2150-5330/full/v15/i2/92791.htm
DOI	https://dx.doi.org/10.4291/wjgp.v15.i2.92791

Full Article (PDF)	WJGP-15-92791-with-cover.pdf
Manuscript File	92791_Auto_Edited-JLW.docx
Answering Reviewers	92791-Answering reviewers.pdf
Audio Core Tip	92791-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	92791-Conflict-of-interest statement.pdf
Copyright License Agreement	92791-Copyright license agreement.pdf
Peer-review Report	92791-Peer-review(s).pdf
Scientific Misconduct Check	92791-Bing-Qu XL-2.jpg
Scientific Editor Work List	92791-Scientific editor work list.pdf
CrossCheck Report	92791-CrossCheck report.pdf